[1] |
PIANO S, BROCCA A, MARESO S, et al. Infections complicating cirrhosis[J]. Liver Int, 2018, 38(Suppl 1): 126-133. DOI: 10.1111/liv.13645.
|
[2] |
SIMONETTO DA, PICCOLO SERAFIM L, GALLO DE MORAES A, et al. Management of sepsis in patients with cirrhosis: Current evidence and practical approach[J]. Hepatology, 2019, 70(1): 418-428. DOI: 10.1002/hep.30412.
|
[3] |
MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144(7): 1426-1437.e1-e9. DOI: 10.1053/j.gastro.2013.02.042.
|
[4] |
ARVANITI V, D'AMICO G, FEDE G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis[J]. Gastroenterology, 2010, 139(4): 1246-1256.e1-e5. DOI: 10.1053/j.gastro.2010.06.019.
|
[5] |
PIANO S, SINGH V, CARACENI P, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide[J]. Gastroenterology, 2019, 156(5): 1368-1380.e10. DOI: 10.1053/j.gastro.2018.12.005.
|
[6] |
RUNYON BA, SQUIER S, BORZIO M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis[J]. J Hepatol, 1994, 21(5): 792-796. DOI: 10.1016/s0168-8278(94)80241-6.
|
[7] |
FERNÁNDEZ J, PRADO V, TREBICKA J, et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe[J]. J Hepatol, 2019, 70(3): 398-411. DOI: 10.1016/j.jhep.2018.10.027.
|
[8] |
EVANS LT, KIM WR, POTERUCHA JJ, et al. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites[J]. Hepatology, 2003, 37(4): 897-901. DOI: 10.1053/jhep.2003.50119.
|
[9] |
European Association for the Study of the Liver. EASL Clinical Practice Guideline: Occupational liver diseases[J]. J Hepatol, 2019, 71(5): 1022-1037. DOI: 10.1016/j.jhep.2019.08.008.
|
[10] |
RUNYON BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012[J]. Hepatology, 2013, 57(4): 1651-1653. DOI: 10.1002/hep.26359.
|
[11] |
LI BL, GAO YH, WANG XB, et al. Clinical features and outcomes of bacterascites in cirrhotic patients: A retrospective, multicentre study[J]. Liver Int, 2020, 40(6): 1447-1456. DOI: 10.1111/liv.14418.
|
[12] |
BUCSICS T, SCHWABL P, MANDORFER M, et al. Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP)[J]. J Hepatol, 2016, 64(6): 1452-1454. DOI: 10.1016/j.jhep.2016.01.039.
|
[13] |
AGIASOTELLI D, ALEXOPOULOU A, VASILIEVA L, et al. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis[J]. Liver Int, 2017, 37(4): 576-582. DOI: 10.1111/liv.13264.
|
[14] |
FERNANDES SR, SANTOS P, FATELA N, et al. Ascitic calprotectin is a novel and accurate marker for spontaneous bacterial peritonitis[J]. J Clin Lab Anal, 2016, 30(6): 1139-1145. DOI: 10.1002/jcla.21994.
|
[15] |
ICHOU L, CARBONELL N, RAUTOU PE, et al. Ascitic fluid TREM-1 for the diagnosis of spontaneous bacterial peritonitis[J]. Gut, 2016, 65(3): 536-538. DOI: 10.1136/gutjnl-2015-310160.
|
[16] |
BRUNS T, SACHSE S, STRAUBE E, et al. Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction[J]. Liver Int, 2009, 29(8): 1206-1214. DOI: 10.1111/j.1478-3231.2009.02073.x.
|
[17] |
FORBES JD, KNOX NC, RONHOLM J, et al. Metagenomics: The next culture-independent game changer[J]. Front Microbiol, 2017, 8: 1069. DOI: 10.3389/fmicb.2017.01069.
|
[18] |
FERNÁNDEZ J, TANDON P, MENSA J, et al. Antibiotic prophylaxis in cirrhosis: Good and bad[J]. Hepatology, 2016, 63(6): 2019-2031. DOI: 10.1002/hep.28330.
|
[19] |
MOREAU R, ELKRIEF L, BUREAU C, et al. Effects of long-term norfloxacin therapy in patients with advanced cirrhosis[J]. Gastroenterology, 2018, 155(6): 1816-1827.e9. DOI: 10.1053/j.gastro.2018.08.026.
|
[20] |
Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
|
[21] |
GRANGE JD, AMIOT X. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis[J]. Gastroenterol Clin Biol, 2000, 24(3): 378-379. https://www.researchgate.net/publication/12451361_Effect_of_intravenous_albumin_on_renal_impairment_and_mortality_in_patients_with_cirrhosis_and_spontaneous_bacterial_peritonitis
|